LAUSR

Dr Bissonnette has received grants and research support, served as a consultant or received honoria from AbbVie, Amgen, Apopharma, Boehringer Ingelheim, Celgene, Dermira, Eli Lilly, Galderma, GSK-Stiefel, Merck, Incyte, Janssen, Kineta, Leo Pharma, Merck, Novartis, Pfizer, Tribute, and Xenoport. Dr Bolduc has served as a consultant or receivedHonoria fromAbbVie, Amgen, Celgene, Eli Lilly, Galderma, GSK-Stiefel, Janssen, Leo Pharma, Merck, Novartis, Tribute, Pfizer, Incyte, and Xenoport. Dr Maari has received grants and research support or received Honoria from AbbVie, Amgen, Apopharma, Boehringer Ingelheim, Celgene, Dermira, Eli Lilly, Galderma, Merck, Incyte, Janssen, Kineta, Leo Pharma, Novartis, Valeant, Pfizer, and Tribute. Dr Nigen has served as a consultant or receivedHonoria fromAbbVie, Amgen, Celgene, Eli Lilly, Galderma, Janssen, Leo Pharma, Merck, Novartis, and Tribute. Dr Delorme served as speaker, advisory board or principal investigator and received Honoria from AbbVie, Actellion, Amgen, Celgene,Dermira, Dignity Science, Eli Lilly, Innovaderm Research, Galderma, Janssen, Kineta, Leo Pharma, Novartis, Regeneron, Vitae, Moberg Pharma, and Cutanea. Dr Lynde served as consultant, speaker, advisory board and principal investigator and received Honoria from AbbVie, Amgen, Boehringer Ingelheim, Celgene, Dermira, and Eli Lilly. Dr Tamaz and Ms Robillard have no conflicts of interest to declare.